Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System

John N. Mafi, MD, MPH; Folasade P. May, MD, PhD; Katherine L. Kahn, MD, MPH; Michelle Chong, MD; Edgar Corona, MPH; Liu Yang, MD, MPH; Margaret M. Mongare, MD; Vishnu Nair, BS; Courtney Reynolds, MD, PhD; Reshma Gupta, MD, MHPM; Cheryl L. Damberg, PhD; Eric Esrailian, MD; Catherine Sarkisian, MD, MSPH


J Am Geriatr Soc. 2019;67(12):2600-2604. 

In This Article


Older adults are receiving PPI prescriptions at an alarmingly high rate, often against guidelines. This study suggests that potentially minor changes in EHR-based stopping rules and/or targeted physician profiling could have a substantial impact on reducing low-value prescribing. These findings will directly inform a system-level QI intervention to curb potentially low-value long-term PPI prescriptions among older adults.